Delivery Order SPE2DB20D3101-SPE2DB25FQWC1

Award Date 12/3/24
Potential Completion Date 12/4/24
Potential Value $62K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FQWC1
    Delivery Order

This federal contract award, with a unique identifier of SPE2DB20D3101|SPE2DB25FQWC1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $61,830.56, is for the delivery of 4566601161 BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product.

The contract has an ultimate completion date of December 4, 2024 and was awarded on December 3, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 3/4/25, 11:12 AM